Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 May;118(2):233–236. doi: 10.1111/j.1476-5381.1996.tb15392.x

Rhythmic relaxations of active tension in the rabbit large arteries induced by a combination of cyclopiazonic acid and Bay K 8644.

M Omote 1, H Mizusawa 1
PMCID: PMC1909617  PMID: 8735620

Abstract

1. We previously demonstrated that cyclopiazonic acid (CPA), an inhibitor of Ca(2+)-ATPase in the sarcoplasmic reticulum, induced rhythmic relaxations of active tension in the endothelium-denuded small arteries of the mesentery and the ear of the rabbit, but that this agent failed to induce rhythmic responses in the endothelium-denuded rabbit femoral artery. 2. In the present study, an attempt was made to induce rhythmic relaxations of active tension in the endothelium-denuded rabbit femoral artery and the thoracic aorta, both of which were suspended in organ chambers for isometric tension recordings, by using CPA plus Bay K 8644, an L-type Ca2+ channel agonist, to induce an excessive increase in cytosolic Ca2+. 3. CPA or Bay K 8644 alone failed to produce rhythmic relaxations in the femoral artery that had been contracted with phenylephrine. In contrast, rhythmic responses were induced by the sequential treatment of the femoral artery with CPA and Bay K 8644. 4. The rhythmic relaxations of active tension in the femoral artery induced by CPA plus Bay K 8644 were inhibited by charybdotoxin and by iberiotoxin, both of which are antagonists of the Ca(2+)-activated K+ channel, but not by glibenclamide, a blocker of the ATP-sensitive K+ channel. 5. The endothelium-denuded rabbit aorta also exhibited rhythmic responses by the sequential addition of CPA and Bay K 8644. These responses were sensitive to charybdotoxin. 6. These findings indicate that, like small arteries, the large femoral and aortic arteries of the rabbit are also capable of displaying rhythmic relaxations of active tension; these relaxations may be in part attributed to the activation of the Ca(2+)-activated K+ channel as a result of the Ca2+ overload caused by CPA and Bay K 8644.

Full text

PDF
233

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashida T., Schaeffer J., Goldman W. F., Wade J. B., Blaustein M. P. Role of sarcoplasmic reticulum in arterial contraction: comparison of ryanodines's effect in a conduit and a muscular artery. Circ Res. 1988 Apr;62(4):854–863. doi: 10.1161/01.res.62.4.854. [DOI] [PubMed] [Google Scholar]
  2. Berridge M. J., Galione A. Cytosolic calcium oscillators. FASEB J. 1988 Dec;2(15):3074–3082. doi: 10.1096/fasebj.2.15.2847949. [DOI] [PubMed] [Google Scholar]
  3. Declerck I., Himpens B., Droogmans G., Casteels R. The alpha 1-agonist phenylephrine inhibits voltage-gated Ca2(+)-channels in vascular smooth muscle cells of rabbit ear artery. Pflugers Arch. 1990 Sep;417(1):117–119. doi: 10.1007/BF00370780. [DOI] [PubMed] [Google Scholar]
  4. Deng H. W., Kwan C. Y. Cyclopiazonic acid is a sarcoplasmic reticulum Ca(2+)-pump inhibitor of rat aortic muscle. Zhongguo Yao Li Xue Bao. 1991 Jan;12(1):53–58. [PubMed] [Google Scholar]
  5. Galvez A., Gimenez-Gallego G., Reuben J. P., Roy-Contancin L., Feigenbaum P., Kaczorowski G. J., Garcia M. L. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem. 1990 Jul 5;265(19):11083–11090. [PubMed] [Google Scholar]
  6. Ganote C. E., Nayler W. G. Contracture and the calcium paradox. J Mol Cell Cardiol. 1985 Aug;17(8):733–745. doi: 10.1016/s0022-2828(85)80035-3. [DOI] [PubMed] [Google Scholar]
  7. Low A. M., Kwan C. Y., Daniel E. E. Evidence for two types of internal Ca2+ stores in canine mesenteric artery with different refilling mechanisms. Am J Physiol. 1992 Jan;262(1 Pt 2):H31–H37. doi: 10.1152/ajpheart.1992.262.1.H31. [DOI] [PubMed] [Google Scholar]
  8. Miller C., Moczydlowski E., Latorre R., Phillips M. Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle. Nature. 1985 Jan 24;313(6000):316–318. doi: 10.1038/313316a0. [DOI] [PubMed] [Google Scholar]
  9. Nelson M. T., Patlak J. B., Worley J. F., Standen N. B. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol. 1990 Jul;259(1 Pt 1):C3–18. doi: 10.1152/ajpcell.1990.259.1.C3. [DOI] [PubMed] [Google Scholar]
  10. Omote M., Mizusawa H. Effects of cyclopiazonic acid on phenylephrine-induced contractions in the rabbit ear artery. Br J Pharmacol. 1994 Jan;111(1):233–237. doi: 10.1111/j.1476-5381.1994.tb14049.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Omote M., Mizusawa H. Endothelium-dependent rhythmic contractions induced by cyclopiazonic acid, a sarcoplasmic reticulum Ca(2+)-pump inhibitor, in the rabbit femoral artery. Acta Physiol Scand. 1995 Jun;154(2):113–119. doi: 10.1111/j.1748-1716.1995.tb09893.x. [DOI] [PubMed] [Google Scholar]
  12. Omote M., Mizusawa H. The role of sarcoplasmic reticulum in endothelium-dependent and endothelium-independent rhythmic contractions in the rabbit mesenteric artery. Acta Physiol Scand. 1993 Sep;149(1):15–21. doi: 10.1111/j.1748-1716.1993.tb09587.x. [DOI] [PubMed] [Google Scholar]
  13. Pauwels P. J., Leysen J. E., Janssen P. A. Ca++ and Na+ channels involved in neuronal cell death. Protection by flunarizine. Life Sci. 1991;48(20):1881–1893. doi: 10.1016/0024-3205(91)90220-6. [DOI] [PubMed] [Google Scholar]
  14. Schramm M., Thomas G., Towart R., Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature. 1983 Jun 9;303(5917):535–537. doi: 10.1038/303535a0. [DOI] [PubMed] [Google Scholar]
  15. Seidler N. W., Jona I., Vegh M., Martonosi A. Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum. J Biol Chem. 1989 Oct 25;264(30):17816–17823. [PubMed] [Google Scholar]
  16. Somlyo A. V., Somlyo A. P. Electromechanical and pharmacomechanical coupling in vascular smooth muscle. J Pharmacol Exp Ther. 1968 Jan;159(1):129–145. [PubMed] [Google Scholar]
  17. Tribe R. M., Borin M. L., Blaustein M. P. Functionally and spatially distinct Ca2+ stores are revealed in cultured vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5908–5912. doi: 10.1073/pnas.91.13.5908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. van Breemen C., Chen Q., Laher I. Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum. Trends Pharmacol Sci. 1995 Mar;16(3):98–105. doi: 10.1016/s0165-6147(00)88990-7. [DOI] [PubMed] [Google Scholar]
  19. van Breemen C., Saida K. Cellular mechanisms regulating [Ca2+]i smooth muscle. Annu Rev Physiol. 1989;51:315–329. doi: 10.1146/annurev.ph.51.030189.001531. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES